Mkhize, P.E. and Viljoen, A. 2025. Leflunomide as an alternative csDMARD for rheumatoid arthritis in a resource-constrained setting: A real-life experience. South African Medical Journal. 115, 4 (May 2025), e2536. DOI:https://doi.org/10.7196/SAMJ.2025.v115i4.2536.